- BMO Capital Markets analyst Keith Bachman retained a Market Perform rating on the shares of Genpact Limited (NYSE:G), lowering the price target to $46 from $53.
- After reiteration of FY23 guidance in the first quarter, the analyst cautioned that the 2H implied revenue ramp raises some risk, even with solid March quarter bookings.
- While large deals and long-natured contracts in 2H is a positive, Genpact has to pave through an “incrementally harder” path to meet guidance going ahead.
- Given the above risks, the analyst does not envision an upside for the firm.
- The analyst notes there is an incremental risk to the guide, as well as risk of gen AI more broadly in IT services longer term.
- However, lower attrition and moving margins are expected to buoy optimism for Genpact.
- Most of the margin expansion will come from an improved mix on existing services to offset large deal dilutive pricing, including more onshore delivery, as well as SG&A efficiency, the analyst added.
- Price Action: G is trading lower by 7.6% to $36.02 in the market session on the last check Thursday.
Stabilis Solutions Q3 EPS $(0.01) Beats $(0.03) Estimate, Sales $25.80M Beat $23.00M Estimate
Stabilis Solutions (NASDAQ:SLNG) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 96.15 percent increase over losses of $(0.26) per share
